dangers of taking glp-1 medication side effects for diabetes and weight loss GLP-1: The Diabetes Drug Changing

ONeil PM, Aroda VR, Astrup A et al (2017) Neuropsychiatric safety with liraglutide 3.0 mg for weight management: results from randomized controlled phase 2 and 3a trials

Wegovy is a brand name for semaglutide, a medication approved for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity

At Cape Fear Physical Medicine and Rehab, our medically supervised GLP-1 weight loss program supports safe and steady progress

Consumers evaluating this category may benefit from prioritizing transparent disclosures, realistic claim language, clear policies, and professional guidance when appropriate

Eat on a schedule rather than waiting for hunger cues that may not come

PMCID: PMC12721889